Email this article The state of cancer care in Russia: pancreas cancer (C25). The survival rate of patients, taking into account the stage, localization and histological structure. Part II (clinical-population study)
- Authors: Merabishvili V.M.1, Bagnenko S.S.1,2, Balakhnin P.V.1, Busko E.A.1,3, Pavlovsky A.V.4, Moiseenko V.E.4,5, Statsenko A.A.4, Perelygin V.V.6
-
Affiliations:
- N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation
- Saint Petersburg State Pediatric Medical University
- Saint Petersburg State University
- Russian Research Center for Radiology and Surgical Technologies
- Pavlov First Saint Petersburg State Medical University (Pavlov University)
- Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian Federation
- Issue: Vol 6, No 3 (2024)
- Pages: 36-46
- Section: Biomedical Sciences
- URL: https://journals.rcsi.science/PharmForm/article/view/272337
- DOI: https://doi.org/10.17816/phf637168
- ID: 272337
Cite item
Full Text
Abstract
Pancreas cancer (С25) is a cancer with an unfavorable prognosis, remains one of the most lethal types of cancer, at the national level mortality exceeds morbidity. The analysis of patient survival at the population level on the scale of federal districts is not carried out in Russia with the exception of the North-West Federal District. Considering that the levels of standardized rates of morbidity and mortality from pancreas cancer are close in Russia and NWFD, and the value of index of accuracy practically coincide, the results of the population cancer registry (PCR) of the NWFD RF actually characterize the state of cancer care on average in Russia, with the exception of autonomous districts. The aim of the second stage of the study was to identify the true state of the effectiveness of the oncological service in Russia by calculating a key parameter – evaluating its performance, specifically, calculating the leading parameter – the survival rate of patients, taking into account the stage, localization, histological structure, and the possibility of curing patients The conducted research made it possible to determine the effectiveness of providing specialized oncological care to patients with pancreas cancer at the federal district level. An increase in the one–year observed survival rate for the period from 2000 to 2004 to 2015-2019 was established from 16.0 to 21.8% or by 36.3%, and five–year from 5.1 to 6.0%. The median survival rate did not reach 4 years. A significant difference in the levels of one-year survival of patients in different age groups has been established. Significant defects in the distribution of patients according to the stage of the disease were revealed. The specification of patient survival by detailed localization groups and major histotypes of tumors was studied.
Full Text
##article.viewOnOriginalSite##About the authors
Vakhtang M. Merabishvili
N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation
Author for correspondence.
Email: MVM@niioncologii.ru
ORCID iD: 0000-0002-1521-455X
SPIN-code: 5705-6327
Honored Scientist of the Russian Federation, Dr.Med.Sci., Professor, Head of the Department of Cancer Statistics; Chairman of the Scientific and Medical Council for the Development of Information Systems of the Oncological Service of the Northwestern Region of Russia; Head of the Population Cancer Registry of the Northwestern Federal District of the Russian Federation
Russian Federation, Saint PetersburgSergey S. Bagnenko
N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation; Saint Petersburg State Pediatric Medical University
Email: bagnenko_ss@mail.ru
ORCID iD: 0000-0002-4131-6293
SPIN-code: 4389-9374
Scopus Author ID: 779096
DSc Med., Professor, Head of Scientific Department, Leading researcher of the N. N. Petrov National Medicine Research Center of Oncology Ministry of health of Russia, Professor of the Department of Radiation Diagnostics and Biomedical Imaging of the Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Pediatric Medical University of the Ministry of Health of Russia
Russian Federation, Saint Petersburg; Saint PetersburgPavel V. Balakhnin
N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation
Email: balahnin_p@mail.ru
PhD in Medical Sciences, Senior Researcher of the Scientific Department of Diagnostic and Interventional Radiology, Head of the Department of X-ray Surgical Methods of Diagnostics and Treatment
Russian Federation, Saint PetersburgEkaterina A. Busko
N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation; Saint Petersburg State University
Email: Katrn@mail.ru
ORCID iD: 0000-0002-0940-6491
SPIN-code: 7323-1083
DSc Med., Assoc. Prof., Leading researcher of the N. N. Petrov National Medicine Research Center of Oncology Ministry of health of Russia; Professor of Saint Petersburg State University
Russian Federation, Saint Petersburg; Saint PetersburgAlexander V. Pavlovsky
Russian Research Center for Radiology and Surgical Technologies
Email: surgepon@gmail.com
DSc Med., Chief Researcher
Russian Federation, Saint PetersburgVladislav E. Moiseenko
Russian Research Center for Radiology and Surgical Technologies; Pavlov First Saint Petersburg State Medical University (Pavlov University)
Email: tmpr@inbox.ru
Candidate of Medical Sciences, Oncologist at the Russian Scientific Center of Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of the Russian Federation; Associate Professor of the Department of Radiology and Surgical Technologies of the First St. Petersburg State Medical University named after Academician I. P. Pavlov of the Ministry of Health of the Russian Federation
Russian Federation, Saint Petersburg; Saint PetersburgAndrey A. Statsenko
Russian Research Center for Radiology and Surgical Technologies
Email: info@rrcrst.ru
MD, PhD, oncologist
Russian Federation, Saint PetersburgVladimir V. Perelygin
Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian Federation
Email: vladimir.pereligin@pharminnotech.com
ORCID iD: 0000-0002-0999-5644
SPIN-code: 3128-7451
Scopus Author ID: 13105602000
ResearcherId: AAV-6556-2020
Dr. Med. Sci., Professor, Honored Doctor of the Russian Federation, Head of the Industrial Ecology Department
Russian Federation, Saint PetersburgReferences
- Berrino F., Capocaccia R., Coleman M. P., Esteve J., Gatta G., Hakulinen T., Micheli M., Sant M., Verdecchia V., eds. Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publications No. 151). Lyon: International Agency for Research on Cancer, 1999.
- Berrino F., Capocaccia R., Esteve J., Gatta G., Hakulinen T., Micheli M., Sant M., Verdecchia V., eds. EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990–94. Ann Oncol 2003;14(Suppl. 5):pp1–155
- Berrino F., Sant M., Verdecchia V., Capocaccia R., Hakulinen T., Estéve J., eds. Survival of cancer patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132). Lyon: International Agency for Research on Cancer, 1995.
- Capocaccia R., Gavin A., Hakulinen T., Lutz J. M., Sant M. (eds.) Survival of cancer patients in Europe, 1995–2002. The EUROCARE-4 study. Eur J Cancer 2009;45.
- De Angelis R., Sant M., Coleman M., Francisci S., Baili P., Pierannunzio D., Trama A., Visser O., Brenner H., Ardanaz E., Bielska-Lasota M., Engholm G., Nennecke A., Siesling S., Berrino F., Capocaccia R., and the EUROCARE-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15:23–34. doi: 10.1016/ S1470-2045(13)70546-1
- Gatta G., Botta L., Rossi S., Aareleid T., Bielska-Lasota M., Clavel J., Dimitrova N., Jakab Z., Kaatsch P., Lacour B., Mallone S., Marcos-Gragera R., Minicozzi P., Sánchez-Pérez M. J., Sant M., Santaquilani M., Stiller C., Tavilla A., Trama A., Visser O., Peris-Bonet R.; EUROCARE Working Group. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014 Jan;15(1):35–47. doi: 10.1016/S1470-2045(13)70548-5.
- Malignant tumors in Russia in 2022 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, A. O. Shakhzadova, I. V. Lisichnikovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2023. – 275 p. (In Russ.)
- Malignant tumors in Russia in 2023 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, A. O. Shakhzadova, I. V. Lisichnikovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2023. – 275 p. (In Russ.)
- Merabishvili V. M. Survival of cancer patients. St. Petersburg: KOSTA, 2011. – 330 p. (In Russ.)
- Merabishvili V. M. Survival of cancer patients. St. Petersburg: KOSTA, 2011. – 408 p. (In Russ.)
- Merabishvili V. M. Oncology statistic. Part I. Second edition, expanded – Saarbrücken, Deutschland (Germany): Lap Lambert Academic Publishing, 2015. – 223 p. (In Russ.)
- Merabishvili V. M. Oncology statistic. Part II. Second edition, expanded – Saarbrücken, Deutschland (Germany): Lap Lambert Academic Publishing, 2015. – 247 p. (In Russ.)
- Belfiori G., Crippa S., Falconi M. ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? Ann Surg Oncol. 2021 Dec;28(13):8261–8262. doi: 10.1245/s10434-021-10402-6
- Belfiori G, Crippa S, Francesca A, Pagnanelli M, Tamburrino D, Gasparini G, Partelli S, Andreasi V, Rubini C, Zamboni G, Falconi M. Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival. Ann Surg Oncol. 2021 Dec;28(13):8249–8260. doi: 10.1245/s10434-021-10401-7.
- Ettrich T. J. Seufferlein T. Systemic Therapy for Metastatic Pancreatic Cancer. Curr Treat Options Oncol. 2021 Oct 19;22(11):106. doi: 10.1007/s11864-021-00895-4.
- Sklyar D. A., Pavlovsky A. V., Polikarpov A. A., Popov S. A., Moiseenko V. E., Meshechkin A. V., Korytova L. I., Granov D. A. Results of complex treatment of patients with operable pancreatic head cancer using preoperative intra-arterial chemotherapy in combination with radiation therapy in multifractionation mode. Medical alphabet. 2021;(37):32–36. doi: 10.33667/2078–5631-2021-37-32-36. (In Russ.)
- Khanevich M. D., Perminova A. A., Manikhas G. M. The use of cryodestruction of pancreatic cancer when it is impossible to perform radical surgery. Bulletin of Pirogov National Medical & Surgical Center. 2023;18(4):36–38. doi: 10.25881/20728255_2023_18_4_36. (In Russ.)
Supplementary files
